Regenerative Medicine

Scope & Guideline

Connecting Minds for Revolutionary Health Solutions

Introduction

Delve into the academic richness of Regenerative Medicine with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1746-0751
PublisherTAYLOR & FRANCIS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2006 to 2024
AbbreviationREGEN MED / Regen. Med.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND

Aims and Scopes

The journal 'Regenerative Medicine' focuses on innovative strategies and methodologies for tissue repair and regeneration, highlighting the intersection of cellular biology, engineering, and clinical applications. It aims to disseminate significant findings that advance the understanding and application of regenerative therapies across various medical fields.
  1. Cellular and Molecular Mechanisms of Regeneration:
    Research in this area investigates the cellular processes and molecular pathways that facilitate regeneration, including stem cell biology, signaling pathways, and gene expression.
  2. Tissue Engineering and Biomaterials:
    This scope encompasses the development and application of biomaterials and scaffolds designed to support tissue regeneration and repair, often integrating biological components to enhance functionality.
  3. Clinical Applications and Translational Research:
    The journal emphasizes the translation of basic research into clinical practice, exploring therapies for conditions such as heart disease, spinal cord injuries, and degenerative disorders.
  4. Regenerative Therapies and Stem Cell Applications:
    Focuses on the use of stem cells and progenitor cells in regenerative medicine, including their potential for tissue repair, immunomodulation, and disease modeling.
  5. Innovative Therapeutic Strategies:
    This area highlights novel approaches in regenerative medicine, including gene editing, exosome therapies, and bioengineering techniques aimed at enhancing tissue repair and regeneration.
Recent trends in 'Regenerative Medicine' publications indicate a clear shift towards innovative techniques and applications that leverage the latest scientific advancements. These emerging themes reflect the evolving landscape of regenerative medicine and its integration with advanced technologies.
  1. In Silico Modeling and Computational Approaches:
    An increasing number of studies utilize computational models to predict outcomes and optimize regenerative strategies, highlighting the importance of data-driven approaches in the field.
  2. Exosome and Extracellular Vesicle Research:
    Research on the role of exosomes and extracellular vesicles in intercellular communication and their therapeutic potential for regeneration has gained momentum, indicating a paradigm shift in understanding regenerative processes.
  3. Personalized and Precision Medicine:
    There is a growing emphasis on tailoring regenerative therapies to individual patient needs, utilizing patient-specific cells or biomaterials to enhance therapeutic outcomes.
  4. Multi-Omics and Systems Biology Approaches:
    Recent publications reflect a trend towards integrating multi-omics data (genomics, proteomics, metabolomics) to gain comprehensive insights into regenerative processes and improve therapeutic strategies.
  5. Neuroregeneration and CNS Repair:
    A notable increase in research focusing on central nervous system regeneration, including novel approaches to promote nerve repair and functional recovery, indicates a growing interest in this critical area.

Declining or Waning

While 'Regenerative Medicine' has consistently explored a wide range of topics, certain themes appear to be losing prominence in recent publications. This decline may reflect shifting research priorities or advancements in methodologies that make some older approaches less relevant.
  1. Traditional Surgical Approaches to Regeneration:
    There seems to be a waning interest in conventional surgical techniques for regeneration, as more emphasis is placed on minimally invasive and biologically-based therapies that leverage cellular and molecular mechanisms.
  2. Focus on Animal Models:
    Research utilizing traditional animal models may be declining as the field increasingly adopts humanized models or in vitro systems that better mimic human physiology and disease.
  3. Single-Agent Therapies:
    There is less focus on therapies that utilize single agents for regeneration, with a notable shift towards combinatorial approaches that enhance therapeutic efficacy through synergy.

Similar Journals

Journal of Tissue Engineering and Regenerative Medicine

Innovating solutions for a healthier tomorrow.
Publisher: WILEYISSN: 1932-6254Frequency: 12 issues/year

Journal of Tissue Engineering and Regenerative Medicine, published by WILEY, stands as a pivotal platform in the fields of biomaterials, biomedical engineering, and regenerative medicine. With an ISSN of 1932-6254 and an E-ISSN of 1932-7005, this journal, based in the United Kingdom, has consistently delivered high-quality research since its inception in 2006, converging critical insights through 2024. With an impressive citation profile reflected in its Scopus rankings—specifically a rank of #58 in Medicine and #75 in Biomedical Engineering—the journal is acknowledged for its substantial impact, as demonstrated by its competitive quartile standings in 2023. Notably, it maintains a Q3 ranking in Biomaterials and Q2 in both Biomedical Engineering and Medicine (miscellaneous), showcasing its influence and relevance in the rapidly evolving interplay between engineering and medicine. The journal serves as a vital resource for researchers and practitioners aiming to stay abreast of innovations and breakthroughs in regenerative therapies, tissue scaffolds, and biomaterials. While not an open-access publication, it fosters academic dialogue and knowledge dissemination that is crucial for advancing the field.

Stem Cells International

Advancing the Frontiers of Stem Cell Research
Publisher: HINDAWI LTDISSN: 1687-966XFrequency:

Stem Cells International is a premier open access journal published by HINDAWI LTD, focusing on the rapidly evolving field of stem cell research. With an ISSN of 1687-966X and E-ISSN 1687-9678, this journal has been a vital resource since its inception in 2010, showcasing innovative studies and breakthroughs up to 2024. Positioned in Q3 in Cell Biology and Q2 in Molecular Biology for 2023, as well as well-ranked in the Scopus database, the journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the implications of stem cell technology in regenerative medicine and biological research. The open access model ensures wide accessibility, fostering collaboration and knowledge-sharing across the scientific community, making it a cornerstone in advancing the understanding and application of stem cell science.

CYTOTECHNOLOGY

Empowering Researchers: Unleashing Potential in Biomedical Innovation.
Publisher: SPRINGERISSN: 0920-9069Frequency: 6 issues/year

CYTOTECHNOLOGY, an esteemed journal published by Springer, stands as a vital resource in the fields of Bioengineering, Biomedical Engineering, and Biotechnology. With an impact factor reflective of its solid position within academia, this journal encompasses a broad scope dedicated to the advancement of cytotechnological research and applications from its inception in 1987 through to its latest volumes in 2024. Based in the Netherlands, it is committed to providing researchers, professionals, and students with high-quality, peer-reviewed articles that contribute to the understanding and innovations in cytotechnology. Although currently not open access, CYTOTECHNOLOGY has garnered a commendable reputation, holding Q3 rankings in multiple categories, indicating its relevance and influence within the scientific community. Researchers are encouraged to submit their cutting-edge findings to share insights that can spark further advancements in this dynamic field.

Regenerative Biomaterials

Bridging Science and Application in Biomaterials
Publisher: OXFORD UNIV PRESSISSN: 2056-3418Frequency: 1 issue/year

Regenerative Biomaterials, published by Oxford University Press, serves as a premier platform for the dissemination of innovative research in the rapidly evolving field of biomaterials. Since its inception in 2014, this esteemed open-access journal has fostered a collaborative and diverse scientific community, providing free access to impactful articles that enhance our understanding of regenerative medicine and tissue engineering. With a commendable impact factor and ranking within the top quartiles of both Biomedical Engineering and Materials Science, it is recognized for its rigorous peer-review process and high-quality publications. The journal aims to bridge the gap between fundamental research and applied sciences, promoting advanced studies that contribute to clinical applications and regeneration strategies. Researchers, practitioners, and students alike are encouraged to engage with the journal’s content to foster interdisciplinary collaboration and drive future innovations in the biomaterials domain.

Inflammation and Regeneration

Catalyzing innovation in cell biology and regenerative science.
Publisher: BMCISSN: Frequency: 1 issue/year

Inflammation and Regeneration is a prominent open-access journal published by BMC, focused on the discerning fields of immunology, cell biology, and regenerative medicine. Since its establishment in 2016, the journal has provided a platform for the dissemination of high-quality research, contributing significantly to the advancement of knowledge in inflammation processes and regenerative therapies. With a remarkable impact reflected in its Q1 quartile rankings in Cell Biology and Immunology for 2023, Inflammation and Regeneration stands out as a leading resource for researchers and practitioners. The journal's commitment to open access ensures that critical findings are readily available to a global audience, fostering collaboration and innovation in the scientific community. With a Scopus ranking that places it in the top 20% of its categories, Inflammation and Regeneration serves as an essential reference for those seeking to stay at the forefront of immunological research and its applications.

Tissue Engineering Part B-Reviews

Advancing the Frontiers of Tissue Engineering.
Publisher: MARY ANN LIEBERT, INCISSN: 1937-3368Frequency: 6 issues/year

Tissue Engineering Part B-Reviews is a premier academic journal published by MARY ANN LIEBERT, INC, focusing on the interdisciplinary field of tissue engineering and regenerative medicine. With an impressive impact factor that places it in the Q1 category across multiple relevant fields—including Biochemistry, Bioengineering, Biomaterials, and Biomedical Engineering—this journal provides a vital platform for researchers and professionals to disseminate cutting-edge findings and comprehensive reviews. Covering a vast scope from 2008 to 2024, the journal is committed to advancing knowledge in the application of engineering principles to biological tissues, making it an indispensable resource for those at the forefront of biomedical innovation. While the journal does not currently offer open access options, its rigorous peer review process ensures high-quality contributions that are essential for academic and practical advancements. The journal's rankings in Scopus reflect its significance, catering to a diverse audience of students, researchers, and practitioners seeking the latest insights in this dynamic field.

Journal of Orthopaedic Translation

Pioneering innovative solutions in orthopedic health.
Publisher: ELSEVIERISSN: 2214-031XFrequency: 4 issues/year

The Journal of Orthopaedic Translation is a leading peer-reviewed publication dedicated to advancing the field of orthopedics through innovative research and clinical implications. Published by Elsevier and available as an Open Access journal since 2013, it ensures that cutting-edge insights and findings are accessible to a global audience, promoting collaboration and knowledge sharing among researchers, professionals, and students. With an impressive impact factor, the journal has achieved a remarkable Q1 ranking in the categories of Orthopedics and Sports Medicine, placing it in the top 1% of journals in this highly specialized field. As of 2023, it ranks #5 out of 321 in conjunction with a notable 98th percentile achievement in Scopus Ranks, underscoring its reputation for excellence and relevance. Through a focus on both basic and applied research, the Journal of Orthopaedic Translation aims to bridge the gap between laboratory and clinical practice, contributing significantly to the evolving landscape of orthopedic health. Join us in exploring the transformative studies shaping the future of patient outcomes and surgical interventions.

STEM CELLS

Exploring breakthroughs in cell and developmental biology.
Publisher: OXFORD UNIV PRESSISSN: 1066-5099Frequency: 12 issues/year

STEM CELLS, published by Oxford University Press, is a leading academic journal dedicated to advancing the field of cell and developmental biology. With an impressive impact factor and ranking in the Q1 and Q2 quartiles across various disciplines, including Developmental Biology and Molecular Medicine, this journal serves as a critical platform for disseminating cutting-edge research findings from 1981 to the present. The journal's rigorous peer-review process ensures the highest quality of published content, making it an essential resource for researchers, healthcare professionals, and students interested in the latest breakthroughs in stem cell research and its applications. With a focus on innovative methodologies and holistic perspectives, STEM CELLS not only highlights significant discoveries but also fosters a collaborative exchange of ideas, driving forward the frontiers of science in regenerative medicine and developmental studies.

DNA AND CELL BIOLOGY

Illuminating the Path of Cellular Advancements
Publisher: MARY ANN LIEBERT, INCISSN: 1044-5498Frequency: 12 issues/year

DNA AND CELL BIOLOGY, published by Mary Ann Liebert, Inc, is a distinguished journal in the realms of cell biology, genetics, and molecular biology, holding a notable position in its Q3 and Q2 quartile rankings across multiple academic categories as of 2023. With an ISSN of 1044-5498 and an E-ISSN of 1557-7430, this journal has been a pivotal platform for the dissemination of cutting-edge research since its inception in 1990, extending its coverage through 2024. Situated in the United States, the journal offers high-quality peer-reviewed articles, exploring significant advancements in biological sciences while fostering interdisciplinary collaborations within the research community. Though it currently does not offer open access, subscribed institutions and individual readers benefit from its rich repository of knowledge. The journal's rigorous standards and impactful content make it an essential resource for researchers, professionals, and students alike, aiming to stay at the forefront of discoveries influencing DNA and cellular dynamics.

Organogenesis

Unveiling the Complexities of Organogenesis.
Publisher: TAYLOR & FRANCIS INCISSN: 1547-6278Frequency: 4 issues/year

Organogenesis is a leading journal published by Taylor & Francis Inc, dedicated to advancing the field of developmental biology and regenerative medicine. With an ISSN of 1547-6278 and E-ISSN 1555-8592, this journal spans an extensive research scope that includes embryology, transplantation, and biomedical engineering, distinguishing itself as a crucial platform for researchers and practitioners alike. Its impact is reflected in its performance across various categories in 2023, earning Q3 rankings in Biomedical Engineering and Embryology, Q4 in Developmental Biology, and Q2 in Transplantation, showcasing its reputable standing among peer journals. Moreover, with Scopus rankings indicating strong positioning in the fields of medicine and biochemistry, Organogenesis is essential for those looking to publish or stay updated on pioneering research. The journal facilitates rigorous peer-review and offers a forum for disseminating innovative findings, making it an invaluable resource for academics, professionals, and students committed to understanding the complexities of organism development.